{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.3616.200.110.102.10002",
  "meta" : {
    "versionId" : "5",
    "lastUpdated" : "2022-12-06T01:03:37.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "Clinical Architecture"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2023-06-21"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2022-12-06"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.10002",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.3.3616.200.110.102.10002"
    }
  ],
  "version" : "20221206",
  "name" : "SARSCoV2VaccinesBivalent",
  "title" : "SARS CoV 2 Vaccines, Bivalent",
  "status" : "active",
  "experimental" : false,
  "date" : "2023-06-21T18:16:37-04:00",
  "publisher" : "Clinical Architecture",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: This set of values contains terms related to),(Data Element Scope: ),(Inclusion Criteria: Includes),(Exclusion Criteria: Excludes)",
  "compose" : {
    "include" : [
      {
        "system" : "http://hl7.org/fhir/sid/cvx",
        "concept" : [
          {
            "code" : "229",
            "display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose"
          },
          {
            "code" : "300",
            "display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation"
          },
          {
            "code" : "301",
            "display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:a0688521-110f-4f26-90ac-75de19f898d4",
    "timestamp" : "2023-11-26T20:09:25-05:00",
    "total" : 3,
    "contains" : [
      {
        "system" : "http://hl7.org/fhir/sid/cvx",
        "version" : "20231102",
        "code" : "229",
        "display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose"
      },
      {
        "system" : "http://hl7.org/fhir/sid/cvx",
        "version" : "20231102",
        "code" : "300",
        "display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation"
      },
      {
        "system" : "http://hl7.org/fhir/sid/cvx",
        "version" : "20231102",
        "code" : "301",
        "display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation"
      }
    ]
  }
}
